ObjectiveThere have been four eras in the development of endovascular aneurysm repair (EVAR): physician-made grafts, early industry devices, intermediary commercial endografts, and modern stent grafts. This study analyzes differences in outcomes between these four groups and the impact of device evolution and increased physician experience.MethodsFrom 1992 to 2012, 1380 patients underwent elective EVAR. Fourteen different devices were used during this time. The four generations were defined as follows: era 1, all physician-made devices; era 2, June 1994 to June 2003; era 3, June 2003 to January 2008; and era 4, January 2008 to July 2012. Grafts used in each era were the following: era 1, physician made; era 2, early industry, such as EVT, T...
AbstractObjectiveThe ENGAGE registry was undertaken to examine the real-world outcome after endovasc...
ObjectiveThe Endurant endograft (Medtronic Inc, Minneapolis, Minn) is a new-generation device specif...
OBJECTIVE: Long-term follow-up after endovascular aneurysm repair (EVAR) is very scarce, and doubt r...
ObjectiveThere have been four eras in the development of endovascular aneurysm repair (EVAR): physic...
ObjectiveWe performed a device-specific comparison of long-term outcomes following endovascular abdo...
BackgroundSince the introduction of endovascular aneurysm repair (EVAR), long-term follow-up studies...
ObjectiveWith more than a decade of use of endovascular aneurysm repair (EVAR), we expect to see a r...
ObjectiveThe Endurant (Medtronic, Minneapolis, Minn) is a new stent graft specifically designed to m...
AbstractObjectiveThis study was undertaken to identify factors that lead to improvements in the resu...
AbstractObjective: The Talent endovascular graft has been used in the treatment of abdominal aortic ...
ObjectiveRecent reports showed that the Endurant stent graft (Medtronic Cardiovascular, Santa Rosa, ...
BackgroundThis study evaluated the early and intermediate results of endovascular aortic aneurysm re...
Objective: Stent graft evolution is often addressed as a cause for improved outcomes of endovascular...
ObjectiveThis study evaluated 1-year safety and effectiveness outcomes of the United States regulato...
AbstractPurpose: to examine the effect of the adoption of endovascular aneurysm repair (EVAR) on the...
AbstractObjectiveThe ENGAGE registry was undertaken to examine the real-world outcome after endovasc...
ObjectiveThe Endurant endograft (Medtronic Inc, Minneapolis, Minn) is a new-generation device specif...
OBJECTIVE: Long-term follow-up after endovascular aneurysm repair (EVAR) is very scarce, and doubt r...
ObjectiveThere have been four eras in the development of endovascular aneurysm repair (EVAR): physic...
ObjectiveWe performed a device-specific comparison of long-term outcomes following endovascular abdo...
BackgroundSince the introduction of endovascular aneurysm repair (EVAR), long-term follow-up studies...
ObjectiveWith more than a decade of use of endovascular aneurysm repair (EVAR), we expect to see a r...
ObjectiveThe Endurant (Medtronic, Minneapolis, Minn) is a new stent graft specifically designed to m...
AbstractObjectiveThis study was undertaken to identify factors that lead to improvements in the resu...
AbstractObjective: The Talent endovascular graft has been used in the treatment of abdominal aortic ...
ObjectiveRecent reports showed that the Endurant stent graft (Medtronic Cardiovascular, Santa Rosa, ...
BackgroundThis study evaluated the early and intermediate results of endovascular aortic aneurysm re...
Objective: Stent graft evolution is often addressed as a cause for improved outcomes of endovascular...
ObjectiveThis study evaluated 1-year safety and effectiveness outcomes of the United States regulato...
AbstractPurpose: to examine the effect of the adoption of endovascular aneurysm repair (EVAR) on the...
AbstractObjectiveThe ENGAGE registry was undertaken to examine the real-world outcome after endovasc...
ObjectiveThe Endurant endograft (Medtronic Inc, Minneapolis, Minn) is a new-generation device specif...
OBJECTIVE: Long-term follow-up after endovascular aneurysm repair (EVAR) is very scarce, and doubt r...